ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed

Zhifang Wang

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-6013-3564; OpenAlex author ID A5100739438.

Their work

Papers: 1 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper

Papers 1

ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p. First author DOI 10.1038/s41419-020-02839-6 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Tingting Wang · 1 shared paper, 2020
- Paper ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p. DOI 10.1038/s41419-020-02839-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.